Stock Market Closed Today for Memorial Day What Investors Should Know Berkshire Hathaway Portfolio Revamp Delta Air Lines and Alphabet Positions Revealed Lake Street Capital Markets Maintains Bullish Stance on Velo3D Following Q1 Earnings Release Judge Drops Indictment in Mistaken Deportation Case Potential Systemic Implications for Immigration Enforcement PutinXi Talks Focus on Power of Siberia 2 as Iran Conflict Shakes Energy Markets Taiwan Emerges as Defining Issue in TrumpXi Talks APOS Q1 2026 Earnings Modest EPS Miss Amid Stable Bond Performance ILPT Q1 2026 Earnings NarrowerthanExpected Loss as Surplus of 3137 Beats Street Estimates ALZN Q1 2026 Earnings Narrowing Losses Beat Estimates by 70 ANVS Q1 2026 Earnings WiderthanExpected Loss Reflects SteppedUp RD Investment UPBD Q1 2026 Earnings EPS Beats Estimates by 247 FLR Q1 2026 Earnings EPS Falls 775 Short of Estimates Stock Gains 077 Alamos Gold AGI Dips 232 as Gold Prices Face Headwinds Key Support at 3642 in Focus Medtronic MDT Slides 1 as Markets Weigh Growth Prospects Key Support in View Wheeler Real Estate Investment Trust WHLR Rallies 49 to 107 Testing Key Resistance Danaher Edges Lower Amid Consolidation Support and Resistance Levels in Focus Seven Hills Realty Trust SEVN Gains 167 as Realty Sector Shows Resilience Morgan Stanley Adjusts Edison International Price Target Amid April Utility Sector Review VICI Properties Q1 2026 Earnings Strong EPS Beat Driven by Resilient Portfolio Performance Sizzle Acquisition Corp II Rights SZZLR Trading at 016 Navigating a Narrow Range DTST Q1 2026 Earnings Narrower Loss Surprises Stock Under Pressure APH Q1 2026 Earnings EPS Beats Estimates by 113 Stock Edges Higher Ralliant Corporation RAL Q1 2026 Earnings Strong EPS Beat Drives Stock Higher VENU Q1 2026 Earnings EPS Misses Estimates as Revenue Figures Remain Undisclosed CRVS Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Pipeline Progress Itau Unibanco ITUB Q1 2026 Earnings EPS Misses Estimates as Net Income Falls Short of Expectations Prime Medicine Inc PRME Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Development Phase